Billiontoone, Inc. (NASDAQ:BLLN) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Billiontoone, Inc. (NASDAQ:BLLN) have been assigned an average recommendation of “Moderate Buy” from the ten analysts that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating on the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $125.2857.

A number of equities research analysts have weighed in on the stock. Guggenheim upped their price target on shares of Billiontoone from $100.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. Wells Fargo & Company cut their price target on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating for the company in a report on Thursday, March 5th. Wall Street Zen raised shares of Billiontoone from a “hold” rating to a “buy” rating in a report on Saturday, March 7th. BTIG Research reduced their price objective on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a research note on Thursday, May 7th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Billiontoone from $120.00 to $125.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th.

Insider Activity at Billiontoone

In other Billiontoone news, CTO David Tsao sold 20,000 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $102.27, for a total transaction of $2,045,400.00. Following the completion of the sale, the chief technology officer directly owned 1,000 shares of the company’s stock, valued at approximately $102,270. This represents a 95.24% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Bosch John Roderick Ten sold 2,832 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $101.47, for a total transaction of $287,363.04. Following the sale, the insider directly owned 34,968 shares of the company’s stock, valued at $3,548,202.96. This represents a 7.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 83,582 shares of company stock valued at $8,312,361.

Hedge Funds Weigh In On Billiontoone

Large investors have recently made changes to their positions in the business. Rossby Financial LCC acquired a new position in shares of Billiontoone in the 4th quarter valued at about $25,000. Wells Fargo & Company MN acquired a new position in Billiontoone in the fourth quarter worth approximately $76,000. Smartleaf Asset Management LLC acquired a new position in Billiontoone in the fourth quarter worth approximately $80,000. Nano Cap New Millennium Growth Fund L P acquired a new position in Billiontoone in the fourth quarter worth approximately $82,000. Finally, Renaissance Capital LLC acquired a new position in Billiontoone in the fourth quarter worth approximately $201,000.

Billiontoone Price Performance

Shares of NASDAQ BLLN opened at $105.15 on Friday. Billiontoone has a twelve month low of $61.96 and a twelve month high of $138.70. The company has a current ratio of 10.92, a quick ratio of 10.58 and a debt-to-equity ratio of 0.18. The company has a market capitalization of $4.84 billion and a price-to-earnings ratio of 191.18. The firm has a 50-day moving average of $89.56 and a two-hundred day moving average of $87.22.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share for the quarter, beating analysts’ consensus estimates of $0.01 by $0.33. The business had revenue of $108.39 million during the quarter, compared to analyst estimates of $95.81 million. During the same period in the previous year, the company posted ($0.39) earnings per share. Billiontoone’s revenue was up 83.8% compared to the same quarter last year. As a group, analysts expect that Billiontoone will post 0.93 earnings per share for the current fiscal year.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.